ArticleSchizophrenia bulletin open2026
Genomic Architecture of Selected Schizophrenia-Associated Regions: Co-location of Non-coding and Protein-Coding Genes.
Article in Schizophrenia bulletin open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-coding RNAs (ncRNAs) are increasingly recognized as important factors in the progression of schizophrenia (SZ); however, their involvement in disease etiology remains incompletely understood. This study aimed to characterize the genomic architecture of selected SZ-associated regions by examining the co-location of ncRNA and protein-coding genes and to explore sequence variants within these regions for potential associations with clinical outcomes. Methods: Genomic regions containing co-located protein-coding and ncRNA genes, specifically those with overlapping exonic sequences, were identified. Functional annotations of the selected SNPs were obtained from Ensembl, including predicted functional effects (SIFT, PolyPhen, CADD) and regulatory features. Association analyses were performed in SZ patients and controls to investigate disease occurrence, treatment response and psychopathological symptoms assessed using the Brief Psychiatric Rating Scale (BPRS). Results: Among 21 selected SZ-associated protein-coding genes (SZGs), seven showed genomic co-location with ncRNA genes. Exonic co-location was identified in four regions: Conclusions: This exploratory study provides insights into the genomic architecture of SZ-associated regions, particularly the co-location between protein-coding SZGs and ncRNAs. It highlights the complexity of the SZ-associated genomic architecture and provides a framework for SNP prioritization and future genomic and functional studies in SZ and related disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.